This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Christopher D. Saudek, MD
Johns Hopkins University School of Medicine Baltimore, Md

JAMA. 1997;278(10):820-821.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The 1-year follow-up of a patient with diabetes¹ struck me as misguided. Dr Rubenstein had presented a rationale for the effective management of type 2 diabetes. In this follow-up, the now 65-year-old patient returned 4 kg heavier, with even worse glycemic control (blood glucose level, 14.4 mmol/L [260 mg/dL]; glycohemoglobin, 11.8%), and highrisk dyslipidemia.

Despite this overall worsening of the patient's risk for complications, the patient and physician appear complacent. Things are going well, the patient is playing tennis, he can allegedly tell when he is out of control, and an optometrist found no subjective visual impairment (not exactly the way to assess retinopathy). "The patient did not want to take insulin." It all reminds me of the line about a man jumping from a 27-story skyscraper, waving to each window as he goes by, saying "Feeling fine so far."

The evidence is beyond question that . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?